Consolidation among big CRO players is reportedly continuing to churn.
Thermo Fisher is nearing a deal to acquire PPD for more than $15 billion, per the Wall Street Journal, and could wrap up a deal as soon as this week. It’s the second potential CRO M&A deal in as many months, following the Icon-PRA Health Sciences deal in late February.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,